Personalized predictions study for a 35 year old woman who takes Chaste Berry, Wellbutrin Xl - from FDA reports


We analyzed 1,190,288 related reports to generate the predictions. There are 2 types of predictions: symptoms and conditions with supporting statistic provided. You can discuss the predictions with your healthcare provider.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

1,190,288 related reports were analyzed:

Most common symptoms:

Depression
  • 7.97% for females aged 35 (±5) who have uterine fibroids and depression
Dizziness
  • 7.75% for females aged 35 (±5) who have uterine fibroids and depression
Drug ineffective
  • 5.01% for females aged 35 (±5) who have uterine fibroids and depression
Fatigue
  • 7.0% for females aged 35 (±5) who have uterine fibroids and depression
  • 5.15% for females aged 35 (±5) who take chaste berry
  • 5.15% for females aged 35 (±5) who take wellbutrin xl
Headache
  • 7.13% for females aged 35 (±5) who have uterine fibroids and depression
  • 5.06% for females aged 35 (±5) who take chaste berry
  • 5.06% for females aged 35 (±5) who take wellbutrin xl
Heavy or prolong menstrual bleeding
  • 9.43% for females aged 35 (±5) who have uterine fibroids
Insomnia
  • 5.24% for females aged 35 (±5) who have uterine fibroids and depression
Nausea
  • 8.6% for females aged 35 (±5) who have uterine fibroids and depression
  • 6.08% for females aged 35 (±5) who take chaste berry
  • 6.08% for females aged 35 (±5) who take wellbutrin xl
Stress and anxiety
  • 8.27% for females aged 35 (±5) who have uterine fibroids and depression
Uterine fibroids
  • 11.32% for females aged 35 (±5) who have uterine fibroids

Most common co-existing conditions:

Birth control
  • 8.27% for females aged 35 (±5) who take chaste berry
  • 8.27% for females aged 35 (±5) who take wellbutrin xl
  • 5.86% for females aged 35 (±5) who have uterine fibroids and depression
Insomnia
  • 5.71% for females aged 35 (±5) who have uterine fibroids and depression
Multiple sclerosis
  • 9.77% for females aged 35 (±5) who take chaste berry
  • 9.77% for females aged 35 (±5) who take wellbutrin xl
Pain
  • 6.78% for females aged 35 (±5) who have uterine fibroids and depression
Uterine fibroids
  • 100.0% for females aged 35 (±5) who have uterine fibroids

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!